249 programming-"Multiple"-"U"-"Prof"-"O.P"-"Duke-University" positions at Nature Careers
Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
contributing to specifically the area of handling spatial data to assess the distribution of several soil properties and fungal communities using samples collected from multiple habitats and land use types at a
-
research group and establish an ambitious research program in the burgeoning research field of Living State Physics. The new professor shall actively engage in education in this field at the NBE department
-
curiosity, innovation and entrepreneurship in all areas Personalized learning programme to foster our staff’s soft and technical skills Multicultural and international work environment with more than 50
-
, including innovations in all that we do An environment encouraging curiosity, innovation and entrepreneurship in all areas Personalized learning programme to foster our staff’s soft and technical skills
-
have performed such studies for a long time and successfully discovered multiple new drug effects under this umbrella. Specifically, this position will work with generating signals within the domain
-
translational science in the field of hematology/oncology/transplant. The Division Director will be an influential leader who will expand our current laboratory-based research programs and collaborate with
-
multiple operating models. Driving a continuous improvement culture of vendor success will be a key accountability. Reporting to a SOPO Leadership role, you will drive strategic initiatives, ensuring
-
contribution Hybrid office working policy, Summer Hours, and paid time off Flexible Spending and Commuter programs Multiple Life insurance options Disability coverage Tuition Assistance Voluntary benefits
-
Multiple Life insurance options Disability coverage Tuition Assistance Voluntary benefits: Identity Theft Protection, Pet Insurance, and Legal Assistance Insurance Employee Assistance Program Family friendly
-
in preclinical testing. The core technology has FDA approval for Phase I trials, but needs optimization on the I.P., scale manufacture and antigen production areas. Our plan is to leverage emerging